Literature DB >> 16755343

Spontaneous alternans in Brugada ECG morphology.

Amir Farjam Fazelifar1, Majid Haghjoo, Arash Arya, Babak Kazemi, Ataollah Bagherzadeh, Mohammad Hosein Nikoo, Mohammad Ali Sadr-Ameli.   

Abstract

A 23-year-old man presented with sick sinus syndrome and Brugada-like ECG pattern. Coved type ECG (type 1) converted to saddleback configuration (type 2) when R-R interval decreased and it changed to coved type pattern with increasing R-R cycle length. During stable heart rate, there was no change in Brugada ECG pattern. The R-R interval effect on these patterns can be explained by intensity or kinetics of ion currents and autonomic tone.

Entities:  

Mesh：

Year:  2006        PMID： 16755343     DOI： 10.1007/s10840-006-8263-x

Source DB:  PubMed          Journal:  J Interv Card Electrophysiol        ISSN： 1383-875X            Impact factor:   1.900


  12 in total

Review 1.  The Brugada syndrome: ionic basis and arrhythmia mechanisms.

Authors:  C Antzelevitch
Journal:  J Cardiovasc Electrophysiol       Date:  2001-02

Review 2.  Proposed diagnostic criteria for the Brugada syndrome: consensus report.

Authors:  Arthur A M Wilde; Charles Antzelevitch; Martin Borggrefe; Josep Brugada; Ramón Brugada; Pedro Brugada; Domenico Corrado; Richard N W Hauer; Robert S Kass; Koonlawee Nademanee; Silvia G Priori; Jeffrey A Towbin
Journal:  Circulation       Date:  2002-11-05       Impact factor: 29.690

3.  A cardiac sodium channel mutation identified in Brugada syndrome associated with atrial standstill.

Authors:  N Takehara; N Makita; J Kawabe; N Sato; Y Kawamura; A Kitabatake; K Kikuchi
Journal:  J Intern Med       Date:  2004-01       Impact factor: 8.989

4.  "Brugada" syndrome: clinical data and suggested pathophysiological mechanism.

Authors:  M Alings; A Wilde
Journal:  Circulation       Date:  1999-02-09       Impact factor: 29.690

5.  Spontaneous T wave alternans in a patient with Brugada syndrome--responses to intravenous administration of class I antiarrhythmic drug, glucose tolerance test, and atrial pacing.

Authors:  Mitsuhiro Nishizaki; Hiroyuki Fujii; Harumizu Sakurada; Akinori Kimura; Masayasu Hiraoka
Journal:  J Cardiovasc Electrophysiol       Date:  2005-02

Review 6.  Electrophysiological basis and genetics of Brugada syndrome.

Authors:  Augustus O Grant
Journal:  J Cardiovasc Electrophysiol       Date:  2005-09

7.  Effects of glucose-induced insulin secretion on ST segment elevation in the Brugada syndrome.

Authors:  Mitsuhiro Nishizaki; Harumizu Sakurada; Takashi Ashikaga; Noriyoshi Yamawake; Hiroyuki Fujii; Masataka Arita; Mitsuaki Isobe; Masayasu Hiraoka
Journal:  J Cardiovasc Electrophysiol       Date:  2003-03

8.  Cellular basis for the Brugada syndrome and other mechanisms of arrhythmogenesis associated with ST-segment elevation.

Authors:  G X Yan; C Antzelevitch
Journal:  Circulation       Date:  1999-10-12       Impact factor: 29.690

9.  Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report.

Authors:  P Brugada; J Brugada
Journal:  J Am Coll Cardiol       Date:  1992-11-15       Impact factor: 24.094

10.  Atrial fibrillation and atrial vulnerability in patients with Brugada syndrome.

Authors:  Hiroshi Morita; Kengo Kusano-Fukushima; Satoshi Nagase; Yoshihisa Fujimoto; Kenichi Hisamatsu; Hideki Fujio; Kayo Haraoka; Makoto Kobayashi; Shiho Takenaka Morita; Kazufumi Nakamura; Tetsuro Emori; Hiromi Matsubara; Kazumasa Hina; Toshimasa Kita; Masahiko Fukatani; Tohru Ohe
Journal:  J Am Coll Cardiol       Date:  2002-10-16       Impact factor: 24.094
View more
  2 in total

1.  Spatially Discordant Repolarization Alternans in the Absence of Conduction Velocity Restitution.

Authors:  Chunli Huang; Zhen Song; Julian Landaw; Zhilin Qu
Journal:  Biophys J       Date:  2020-02-15       Impact factor: 4.033

2.  The pathophysiological mechanism underlying Brugada syndrome: depolarization versus repolarization.

Authors:  Arthur A M Wilde; Pieter G Postema; José M Di Diego; Sami Viskin; Hiroshi Morita; Jeffrey M Fish; Charles Antzelevitch
Journal:  J Mol Cell Cardiol       Date:  2010-07-24       Impact factor: 5.000
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.